4th Quarter 2025 Earnings Release Presentation February 11, 2026 Cautionary Statements This presentation includes "forward looking statements." These statements relate to future events, including, but not limited to, statements regarding our liquidity, operating results, future earnings, financial position, operational and strategic initiatives, and developments in legislation, regulation, and the healthcare industry more generally. These forward-looking statements represent management's expectations, based ...

A lot of the gains were concentrated in just a handful of areas. These were not broad-based gains. So, let's go to Yahoo Finance's Brooke Deal for more details on that.Hey, Brooke. Julie, good morning. Certainly, that's right.What we saw in 2025 really continued into January of 2026 with healthcare once again being the largest gainer during the month of January. As you can see here on screen, the healthcare sector gained about 82,000 jobs. And breaking that down further, about 50,000 ambulatory jobs were ad ...

Core Insights - Hillsboro Health has selected Oracle Health solutions to enhance patient care, optimize operations, and drive innovation [1] - The hospital will transition to Oracle Health Foundation EHR and implement Oracle Health Clinical AI Agent and Oracle Health Seamless Exchange [1] Company Overview - Hillsboro Health is a 25-bed independent critical access hospital located in Hillsboro, Illinois, providing a range of services including emergency, inpatient, outpatient, and specialty care [1] - The organization is focused on expanding and modernizing its services while standardizing clinical systems with Oracle Health [1] Technology Implementation - The integration of Oracle Health Foundation EHR aims to streamline documentation processes and improve provider satisfaction [1] - Oracle Health Clinical AI Agent will automate clinical documentation, allowing clinicians to spend more time with patients [1] - Oracle Health Seamless Exchange will enable clinicians to securely aggregate data from various sources, creating comprehensive patient records [1] Strategic Goals - The CEO of Hillsboro Health emphasized the importance of integrating clinical systems to enhance care services across the network [1] - Oracle Health aims to support rural healthcare settings with AI-powered solutions to maximize staff impact and improve care delivery [1]

NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a class action lawsuit against Ardent Health, Inc. (NYSE:ARDT) and certain of the Company’s senior executives for securities fraud after a significant stock drop resulting from potential violations of the federal securities laws. If you invested in Ardent Health, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ardent-health-inc-class-act ...

Core Insights - Tenet Healthcare Corporation reported strong financial results for the fourth quarter and full year 2025, with a net income of $371 million or $4.22 per diluted share in Q4 2025, reflecting a 16.7% increase from Q4 2024 [1][2] - Adjusted diluted earnings per share rose 36.6% to $4.70 in Q4 2025 compared to $3.44 in Q4 2024, driven by robust revenue growth and disciplined expense management [1][2] - The company anticipates FY 2026 Adjusted EBITDA to be between $4.485 billion and $4.785 billion, indicating continued growth expectations [1][2] Financial Performance - Q4 2025 net operating revenues reached $5.527 billion, up 8.9% from $5.073 billion in Q4 2024, while FY 2025 revenues totaled $21.310 billion, a 3.1% increase from $20.675 billion in FY 2024 [1][5] - Consolidated Adjusted EBITDA for Q4 2025 was $1.183 billion, a 12.9% increase from $1.048 billion in Q4 2024, with an Adjusted EBITDA margin of 21.4% [1][2] - The company generated free cash flow of $2.53 billion in FY 2025, compared to $1.116 billion in FY 2024, highlighting improved cash generation capabilities [1][5] Segment Performance - The Ambulatory Care segment reported Q4 2025 net operating revenues of $1.433 billion, a 13.8% increase from $1.259 billion in Q4 2024, driven by strong same-facility net patient service revenues [2][6] - The Hospital Operations segment saw Q4 2025 net operating revenues of $4.094 billion, a 7.3% increase from $3.814 billion in Q4 2024, attributed to favorable payer mix and higher acuity services [2][6] - Adjusted EBITDA for the Ambulatory segment was $580 million in Q4 2025, up 9.4% from $530 million in Q4 2024, while the Hospital segment's Adjusted EBITDA increased to $603 million from $518 million in the same period [2][6] Balance Sheet and Cash Flow - Cash flows from operating activities for FY 2025 were $3.54 billion, significantly higher than $2.047 billion in FY 2024, reflecting improved operational efficiency [1][5] - The company repurchased 8.8 million shares for $1.386 billion in FY 2025, indicating a commitment to returning value to shareholders [1][5] - As of December 31, 2025, the ratio of net debt to Adjusted EBITDA was 2.25x, down from 2.54x a year earlier, indicating improved leverage [1][5] 2026 Financial Outlook - For FY 2026, Tenet expects net operating revenues to be between $21.500 billion and $22.300 billion, with net income available to common stockholders projected between $2.605 billion and $2.840 billion [2][6] - The company anticipates Adjusted EBITDA margins to range from 20.9% to 21.5% in FY 2026, reflecting continued operational improvements [2][6] - The Ambulatory segment is expected to see net operating revenues of $5.500 billion to $5.700 billion, while the Hospital segment is projected to generate $16.000 billion to $16.600 billion in revenues [2][6]

Core Insights - The article highlights the integration of AI and traditional Chinese medicine (TCM) at Jiangsu Haibin Rehabilitation Hospital, showcasing successful health transformations of patients through a six-dimensional health management system [1][3][4]. Group 1: Patient Transformations - Patient Mr. Lu, aged 49, experienced significant health improvements, losing 6 kg of body fat and reducing his waist circumference by 5 cm, while discontinuing hypertension medication after three months of treatment [1]. - Another patient, Mr. Yuan, aged 42, increased his skeletal muscle mass by 2.9 kg and reduced his body fat percentage from 27.1% to 21.4% through a personalized health management plan based on AI diagnostics [3]. Group 2: Technological Integration - The hospital's core technology, the AI-based TCM diagnostic device, has accurately assessed over 2,600 patients, achieving a diagnostic accuracy rate of over 90% when compared to experienced TCM practitioners [4]. - The hospital has upgraded its traditional herbal medicine preparation methods with fully automated machines, improving efficiency by 50% compared to manual processes, making TCM more accessible for families [4]. Group 3: Holistic Health Management - The six-dimensional health management system encompasses diet, exercise, sleep, psychology, daily routines, and environment, tailored for all age groups, positioning TCM as a vital component of modern health care [7]. - The hospital aims to integrate TCM wisdom into daily family life, promoting a healthier lifestyle through technology and personalized services [7]. Group 4: Community Engagement and Education - The hospital has created an engaging environment for health education, utilizing AI and historical medical knowledge to provide personalized health advice to various age groups [6]. - The integration of traditional music therapy with TCM principles in the hospital's garden enhances the overall patient experience, making health management enjoyable and culturally enriching [6].

Core Insights - Tenet Healthcare Corporation (THC) is scheduled to report its fourth-quarter 2025 results on February 11, 2026, with earnings estimated at $4.08 per share and revenues of $5.45 billion [1] Financial Performance Estimates - The fourth-quarter earnings estimate has increased by $0.03 over the past 60 days, indicating a year-over-year increase of 18.6% [2] - The Zacks Consensus Estimate for quarterly revenues suggests a year-over-year growth of 7.5% [2] - For the full year 2025, the revenue estimate is $21.26 billion, reflecting a 2.9% year-over-year rise, while the earnings per share estimate is $16.15, indicating a 35.9% increase year-over-year [3] Earnings Prediction Model - The current model does not predict a definitive earnings beat for THC, as it has an Earnings ESP of +2.72% and a Zacks Rank of 4 (Sell) [4] Q4 Results Influencing Factors - THC is expected to report Q4 EPS of $4.08, up 18.6% year-over-year, with revenues projected to rise by 7.5% [7] - Hospital patient days and average length of stay are projected to decline sharply in Q4 [7] - The Ambulatory Care segment is anticipated to experience strong growth, with operating revenues expected to rise [7] - Adjusted patient admissions in total hospital operations are estimated to grow by 3.9% year-over-year, while adjusted patient admissions on the same hospital basis indicate a 2.7% increase [8] Ambulatory Care Segment Performance - The Ambulatory Care business is likely to benefit from improved patient volumes, new service line growth, and acquisitions, with operating revenues expected to grow by 8.4% year-over-year [9] - The consensus estimate for adjusted EBITDA from Ambulatory Care operations suggests a 9% year-over-year growth [9] Hospital Operations and Services - The Zacks Consensus Estimate for Hospital Operations and Services revenues for Q4 is $4.07 billion, indicating a 6.9% increase from the previous year [10] - The consensus mark for net patient revenues per adjusted admission signals a 4.5% year-over-year increase [10] Challenges and Cost Considerations - Despite expected growth, total hospital patient days are projected to decrease by 6.5% year-over-year, and the average length of stay is expected to decline by 8.8% [11][12] - Increased utilization is anticipated to lead to higher costs in Q4, making an earnings beat uncertain [12] Industry Comparisons - Other companies in the medical sector, such as HCA Healthcare, Ensign Group, and Encompass Health, have reported their Q4 results, with varying degrees of performance against consensus estimates [13][14][15]

转自：衢州日报 记者 腊莎 整理 2月16日—2月19日（除夕至正月初三）就诊安排： 1.普内科、普外科、呼吸与危重症医学科、消化内科、心血管内科，在2楼B1区（内分泌代谢门诊区） 候诊。 2.妇科在4楼A1区候诊。 （来源：衢州日报） 2.专家门诊如下： 普通精神科2月15日（星期日）上午、2月18日（正月初二）、2月19日（正月初三）上午、2月20日（正 月初四）上午、2月21日（正月初五）上午、2月22日（正月初六）上午、2月23日（正月初七）上午及 下午开诊。 1.2月16日（除夕）—2月18日（正月初二）开设针灸推拿、中医内科门诊，同时提供中医传统疗法治疗 （3号楼一楼），儿科开设急诊儿科（7号楼一楼）。2月19日（正月初三）起门诊恢复正常。 2.健康管理中心2月15日—2月23日停诊。 三、院外医疗点安排： 3.儿科在1楼B1区候诊。 4.发热门诊和急诊24小时开诊。 ●衢州市中医医院 一、急诊24小时开诊。 二、本院门诊安排： 1.国资大厦医疗点2月16日（除夕）—2月23日（正月初七）停诊。 2.智慧新城院区2月16日（除夕）—2月22日（正月初六）停诊。 3.北门街医疗点中医、夜间门诊2月1 ...

Core Viewpoint - The Ardent Health class action lawsuit alleges that the company and its executives made misleading statements regarding financial practices and liability reserves, leading to significant stock price declines following revelations of financial mismanagement [3][4]. Group 1: Allegations and Financial Impact - The lawsuit claims that Ardent Health did not rely on accurate methods for determining the collectability of accounts receivable, which inflated reported financial positions [3]. - On November 12, 2025, Ardent Health disclosed a $43 million decrease in third quarter 2025 revenue due to revised accounts receivable assessments, resulting in a nearly 34% drop in stock price [4]. - The company cut its 2025 EBITDA guidance by approximately 9.6%, from a range of $575 million - $615 million to $530 million - $555 million, citing persistent industry-wide cost pressures [4]. Group 2: Class Action Details - Investors who purchased Ardent Health securities between July 18, 2024, and November 12, 2025, can seek appointment as lead plaintiff in the class action lawsuit [1][5]. - The lead plaintiff will represent the interests of all class members and can select a law firm to litigate the case [5]. - Robbins Geller Rudman & Dowd LLP, the firm handling the case, is recognized as a leading complex class action firm with a strong track record in securities fraud litigation [6].

RT Rupert Lowe MP (@RupertLowe10)Today at the inquiry we're focusing on the NHS, who in my view have as many questions to answer as the police.Young girls presenting with sexually transmitted infections, miscarriages? Wounds from obvious beatings? Clear signs of rape?Did nobody senior enough in these hospitals think to seriously sound the alarm? When hundreds of young girls are coming in, beaten?Individuals across senior management in certain NHS trusts knew EXACTLY what was going on, and did nothing.They s ...